Brief: Oncology Institute - On June 20, Got Notice From Nasdaq Indicating That Co Is No Longer In Compliance With Nasdaq Listing Rule 5550(A)(2)
21/06/2024 21:43
Oncology Institute Inc TOI.O :
* ONCOLOGY INSTITUTE - ON JUNE 20, GOT NOTICE FROM NASDAQ
INDICATING THAT CO IS NO LONGER IN COMPLIANCE WITH NASDAQ
LISTING RULE 5550(A)(2)
Source text for Eikon: ID:n0001079973-24-000949
Further company coverage: TOI.O
Recent news on Starling Oncology
See all newsBrief: Starling Oncology Unit Enters Credit Agreement On August 20
Brief: Starling Oncology Q2 EPS USD -0.08
Brief: Oncology Institute Rebrands As Starling Oncology
Oncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million